Head-to-Head

Abbott Laboratories vs. Avalo Therapeutics, Inc. Common Stock

ABT

Abbott Laboratories

$102.51 +1.99%

VS AVTX

Avalo Therapeutics, Inc. Common Stock

$7.45 -39.23%

Abbott Laboratories (ABT) comes out ahead, leading on 2 of 2 compared factors.

Size & Scale

ABTAVTX
Market Cap $173.92 billion $657.50 million

ABT leads on 1 of 1 size & scale factors.

Dividend

ABTAVTX
Dividend Yield 2.46% —

ABT and AVTX split the dividend factors evenly.

Risk & Sentiment

ABTAVTX
Short Interest 0.57% 4.95%

ABT leads on 1 of 1 risk & sentiment factors.

Dig deeper: ABT overview, ABT financials, AVTX overview, AVTX financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.